United Capital Financial Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$654K Buy
7,602
+117
+2% +$10.3K ﹤0.01% 988
2026
Q1
$677K Buy
7,485
+3,109
+71% +$285K ﹤0.01% 921
2025
Q4
$393K Sell
4,376
-879
-17% -$83.3K ﹤0.01% 1060
2025
Q3
$518K Buy
5,255
+707
+16% +$70.1K ﹤0.01% 848
2025
Q2
$415K Sell
4,548
-949
-17% -$91.8K ﹤0.01% 828
2025
Q1
$622K Buy
5,497
+388
+8% +$41.5K 0.01% 687
2024
Q4
$540K Sell
5,109
-6
-0.1% -$644 ﹤0.01% 716
2024
Q3
$552K Sell
5,115
-2,233
-30% -$244K ﹤0.01% 704
2024
Q2
$797K Sell
7,348
-383
-5% -$45.1K 0.01% 582
2024
Q1
$1.02M Sell
7,731
-944
-11% -$118K 0.01% 555
2023
Q4
$1.06M Sell
8,675
-2,221
-20% -$248K 0.01% 549
2023
Q3
$1.22M Sell
10,896
-651
-6% -$82.7K 0.01% 481
2023
Q2
$1.68M Sell
11,547
-560
-5% -$76.1K 0.01% 463
2023
Q1
$1.56M Sell
12,107
-438
-3% -$55K 0.01% 489
2022
Q4
$1.6M Sell
12,545
-184
-1% -$21.4K 0.01% 523
2022
Q3
$1.33M Buy
12,729
+74
+0.6% +$8.12K 0.01% 552
2022
Q2
$1.33M Buy
12,655
+645
+5% +$76.5K 0.01% 576
2022
Q1
$1.54M Sell
12,010
-1,124
-9% -$135K 0.01% 575
2021
Q4
$1.62M Sell
13,134
-608
-4% -$79.6K 0.01% 582
2021
Q3
$1.95M Sell
13,742
-559
-4% -$82.2K 0.01% 530
2021
Q2
$2.23M Buy
14,301
+24
+0.2% +$3.89K 0.01% 514
2021
Q1
$2.22M Buy
14,277
+470
+3% +$72.8K 0.01% 489
2020
Q4
$2.07M Sell
13,807
-3,329
-19% -$470K 0.01% 498
2020
Q3
$2.27M Sell
17,136
-509
-3% -$66.5K 0.01% 469
2020
Q2
$2.04M Sell
17,645
-50
-0.3% -$5.76K 0.01% 511
2020
Q1
$1.74M Sell
17,695
-1,851
-9% -$243K 0.01% 525
2019
Q4
$2.82M Sell
19,546
-1,593
-8% -$220K 0.02% 533
2019
Q3
$2.82M Sell
21,139
-1,367
-6% -$177K 0.02% 521
2019
Q2
$2.57M Sell
22,506
-6,828
-23% -$800K 0.02% 551
2019
Q1
$3.64M Buy
29,334
+12,926
+79% +$1.47M 0.03% 466
2018
Q4
$1.65M Sell
16,408
-551
-3% -$62K 0.01% 601
2018
Q3
$2.17M Buy
16,959
+30
+0.2% +$3.57K 0.02% 594
2018
Q2
$1.83M Sell
16,929
-423
-2% -$46K 0.01% 612
2018
Q1
$1.84M Buy
17,352
+354
+2% +$41.1K 0.01% 612
2017
Q4
$2.01M Sell
16,998
-1,766
-9% -$200K 0.02% 584
2017
Q3
$2.13M Sell
18,764
-923
-5% -$107K 0.02% 555
2017
Q2
$2.45M Buy
19,687
+1,034
+6% +$123K 0.02% 521
2017
Q1
$2.21M Sell
18,653
-641
-3% -$72.7K 0.02% 541
2016
Q4
$1.93M Sell
19,294
-3,663
-16% -$393K 0.02% 573
2016
Q3
$2.9M Sell
22,957
-1,823
-7% -$225K 0.03% 489
2016
Q2
$2.89M Sell
24,780
-4,513
-15% -$511K 0.03% 470
2016
Q1
$3.03M Sell
29,293
-1,643
-5% -$159K 0.03% 447
2015
Q4
$3.08M Sell
30,936
-2,624
-8% -$257K 0.04% 450
2015
Q3
$3.06M Sell
33,560
-874
-3% -$87.6K 0.04% 431
2015
Q2
$3.65M Buy
34,434
+3,185
+10% +$352K 0.04% 429
2015
Q1
$3.33M Buy
31,249
+427
+1% +$48.7K 0.04% 435
2014
Q4
$3.39M Buy
30,822
+5,987
+24% +$631K 0.05% 346
2014
Q3
$2.42M Sell
24,835
-128
-0.5% -$12.6K 0.04% 394
2014
Q2
$2.52M Sell
24,963
-156
-0.6% -$15.2K 0.05% 369
2014
Q1
$2.31M Sell
25,119
-346
-1% -$31.9K 0.05% 336
2013
Q4
$2.3M Sell
25,465
-4,227
-14% -$366K 0.08% 226
2013
Q3
$2.37M Sell
29,692
-7,838
-21% -$617K 0.08% 233
2013
Q2
$2.73M Buy
+37,530
New +$2.81M 0.07% 268

Other funds holding ZBH

United Capital Financial Advisors's ZBH Position: Q2 2026 in Review

United Capital Financial Advisors increased its Zimmer Biomet (ZBH) stake by 1.6% in Q2 2026, buying an estimated $10.3K and bringing the position to 7,602 shares worth $654K. The position accounts for ﹤0.01% of the portfolio, ranked #988.

United Capital Financial Advisors first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.65M in Q2 2015. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • United Capital Financial Advisors held 7,602 shares of Zimmer Biomet worth $654K as of Q2 2026.
  • United Capital Financial Advisors bought 117 Zimmer Biomet shares in Q2 2026, an estimated $10.3K.
  • Zimmer Biomet made up ﹤0.01% of United Capital Financial Advisors's portfolio in Q2 2026, its #988 holding.
  • United Capital Financial Advisors first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
  • United Capital Financial Advisors's Zimmer Biomet position peaked at $3.65M in Q2 2015.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on United Capital Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.